awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47787457-0F2FDADC-E957-41EF-80CA-56C4427E9B37
Q47787457-0F2FDADC-E957-41EF-80CA-56C4427E9B37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47787457-0F2FDADC-E957-41EF-80CA-56C4427E9B37
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam.
P2860
Q47787457-0F2FDADC-E957-41EF-80CA-56C4427E9B37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47787457-0F2FDADC-E957-41EF-80CA-56C4427E9B37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9682a616991242a5c09a40b439555b9472b73773
P2860
Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.